Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Jan. 20, 2026. Document 2026-00954. Updated Nov. 15, 2026.
- What it does
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one (commonly known as 2-fluorodeschloroketamine or 2-FDCK), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 2-fluorodeschloroketamine.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What it would change
1 part of Title 21 of the Code of Federal Regulations:
- What happens next and when
January 20, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2026-00954 |
|---|---|
| Action | Proposed amendment; notice of intent. |
| Agencies | Justice Department; Drug Enforcement Administration |
| Published | Jan. 20, 2026 |
| Docket | DEA-2026-0133 |
Source: the Federal Register (public domain). The document in the Federal Register